Advertisement
Research Article

APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells

  • Gregory Berger,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Stéphanie Durand,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Guillaume Fargier,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Xuan-Nhi Nguyen,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Stéphanie Cordeil,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Serge Bouaziz,

    Affiliation: UMR 8015 CNRS, University Paris Descartes, Paris, France

    X
  • Delphine Muriaux,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Jean-Luc Darlix,

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Andrea Cimarelli mail

    acimarel@ens-lyon.fr

    Affiliations: Department of Human Virology, ENS-L, Lyon, France, INSERM, U758, Lyon, France, University of Lyon, Lyon I, IFR128, Lyon, France

    X
  • Published: September 22, 2011
  • DOI: 10.1371/journal.ppat.1002221

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.